![Rik van Heijningen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rik van Heijningen is a Director of ART Advanced Research Technologies, Inc. Prior to joining ART Advanced Research Technologies, Mr. van Heijningen held various sales, marketing and business leadership positions at Kreatech Biotechnology BV, including Interim Vice President Commercial Operations.
He held various leadership positions at Invitrogen BV and Dynal Biotech ASA. Mr. van Heijningen spent the last 20 years in the research, discovery and preclinical market arena.
He held various sales, marketing and business leadership positions at Dynal Biotech LLC, including Senior Sales Manager, General Manager of Germany and Interim Vice President of Tissue Typing.
Mr. van Heijningen was a Clinical Oncology Research Technician at the Academic Hospital of the Free University.
He received an MBA from the University of Birmingham, England and completed university studies in biochemistry.
| Sociétés | Poste | Fin |
|---|---|---|
| ART ADVANCED RESEARC | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
ART Advanced Research Technologies, Inc.
 ART Advanced Research Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets laser and thermal imaging technologies | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
